260 related articles for article (PubMed ID: 24349473)
21. Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes.
Vega F; Cho-Vega JH; Lennon PA; Luthra MG; Bailey J; Breeden M; Jones D; Medeiros LJ; Luthra R
Br J Haematol; 2008 Jun; 142(2):216-26. PubMed ID: 18492102
[TBL] [Abstract][Full Text] [Related]
22. Exome sequencing identifies recurrent
Jallades L; Baseggio L; Sujobert P; Huet S; Chabane K; Callet-Bauchu E; Verney A; Hayette S; Desvignes JP; Salgado D; Levy N; Béroud C; Felman P; Berger F; Magaud JP; Genestier L; Salles G; Traverse-Glehen A
Haematologica; 2017 Oct; 102(10):1758-1766. PubMed ID: 28751561
[TBL] [Abstract][Full Text] [Related]
23. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
Rossi D; Deaglio S; Dominguez-Sola D; Rasi S; Vaisitti T; Agostinelli C; Spina V; Bruscaggin A; Monti S; Cerri M; Cresta S; Fangazio M; Arcaini L; Lucioni M; Marasca R; Thieblemont C; Capello D; Facchetti F; Kwee I; Pileri SA; Foà R; Bertoni F; Dalla-Favera R; Pasqualucci L; Gaidano G
Blood; 2011 Nov; 118(18):4930-4. PubMed ID: 21881048
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas.
Robledo C; García JL; Benito R; Flores T; Mollejo M; Martínez-Climent JÁ; García E; Gutiérrez NC; Piris MA; Hernández JM
PLoS One; 2011; 6(9):e24939. PubMed ID: 21957467
[TBL] [Abstract][Full Text] [Related]
25. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
[TBL] [Abstract][Full Text] [Related]
26. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
[TBL] [Abstract][Full Text] [Related]
27. Nodal and splenic marginal zone B cell lymphomas.
Mollejo M; Camacho FI; Algara P; Ruiz-Ballesteros E; García JF; Piris MA
Hematol Oncol; 2005; 23(3-4):108-18. PubMed ID: 16307458
[TBL] [Abstract][Full Text] [Related]
28. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
[TBL] [Abstract][Full Text] [Related]
30. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
[TBL] [Abstract][Full Text] [Related]
31. Splenic marginal-zone lymphoma: ontogeny and genetics.
Baliakas P; Strefford JC; Bikos V; Parry M; Stamatopoulos K; Oscier D
Leuk Lymphoma; 2015 Feb; 56(2):301-10. PubMed ID: 24798744
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
[TBL] [Abstract][Full Text] [Related]
33. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.
Dunn-Walters DK; Boursier L; Spencer J; Isaacson PG
Hum Pathol; 1998 Jun; 29(6):585-93. PubMed ID: 9635678
[TBL] [Abstract][Full Text] [Related]
34. Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma.
Anagnostou T; Yang ZZ; Jalali S; Kim HJ; Larson DP; Tang X; Yu Y; Pritchett JC; Bisneto JV; Price-Troska TL; Mondello P; Novak AJ; Ansell SM
Leukemia; 2023 Jul; 37(7):1485-1498. PubMed ID: 37117318
[TBL] [Abstract][Full Text] [Related]
35. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
36. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
[TBL] [Abstract][Full Text] [Related]
37. Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Bonfiglio F; Bruscaggin A; Guidetti F; Terzi di Bergamo L; Faderl M; Spina V; Condoluci A; Bonomini L; Forestieri G; Koch R; Piffaretti D; Pini K; Pirosa MC; Cittone MG; Arribas A; Lucioni M; Ghilardi G; Wu W; Arcaini L; Baptista MJ; Bastidas G; Bea S; Boldorini R; Broccoli A; Buehler MM; Canzonieri V; Cascione L; Ceriani L; Cogliatti S; Corradini P; Derenzini E; Devizzi L; Dietrich S; Elia AR; Facchetti F; Gaidano G; Garcia JF; Gerber B; Ghia P; Gomes da Silva M; Gritti G; Guidetti A; Hitz F; Inghirami G; Ladetto M; Lopez-Guillermo A; Lucchini E; Maiorana A; Marasca R; Matutes E; Meignin V; Merli M; Moccia A; Mollejo M; Montalban C; Novak U; Oscier DG; Passamonti F; Piazza F; Pizzolitto S; Rambaldi A; Sabattini E; Salles G; Santambrogio E; Scarfò L; Stathis A; Stüssi G; Geyer JT; Tapia G; Tarella C; Thieblemont C; Tousseyn T; Tucci A; Vanini G; Visco C; Vitolo U; Walewska R; Zaja F; Zenz T; Zinzani PL; Khiabanian H; Calcinotto A; Bertoni F; Bhagat G; Campo E; De Leval L; Dirnhofer S; Pileri SA; Piris MA; Traverse-Glehen A; Tzankov A; Paulli M; Ponzoni M; Mazzucchelli L; Cavalli F; Zucca E; Rossi D
Blood; 2022 Feb; 139(5):732-747. PubMed ID: 34653238
[TBL] [Abstract][Full Text] [Related]
38. A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma.
Ozawa MG; Bhaduri A; Chisholm KM; Baker SA; Ma L; Zehnder JL; Luna-Fineman S; Link MP; Merker JD; Arber DA; Ohgami RS
Mod Pathol; 2016 Oct; 29(10):1212-20. PubMed ID: 27338637
[TBL] [Abstract][Full Text] [Related]
39. Splenic marginal zone lymphoma.
Oscier D; Owen R; Johnson S
Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.
Algara P; Mateo MS; Sanchez-Beato M; Mollejo M; Navas IC; Romero L; Solé F; Salido M; Florensa L; Martínez P; Campo E; Piris MA
Blood; 2002 Feb; 99(4):1299-304. PubMed ID: 11830479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
